Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-03-16

Clinical Trial Update: Dietary and Topical Magnesium Replacement or Supplementation in Patients With Lymphoma [EARLY_Phase 1]

View source ↗

Summary

A Phase 1 clinical trial is recruiting to evaluate dietary and topical magnesium replacement or supplementation in patients with lymphoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Magnesium supplement (dietary/topical) (magnesium)

Snippet

Sponsor: Mayo Clinic | Conditions: Lymphoma | EARLY_Phase 1 | Status: RECRUITING